RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Immuno-Biological Laboratories Co Stock

Immuno-Biological Laboratories Co ROCE 2024

Immuno-Biological Laboratories Co ROCE

0.08

Ticker

4570.T

ISIN

JP3921300004

In 2024, Immuno-Biological Laboratories Co's return on capital employed (ROCE) was 0.08, a -192.29% increase from the -0.09 ROCE in the previous year.

Immuno-Biological Laboratories Co Aktienanalyse

What does Immuno-Biological Laboratories Co do?

Immuno-Biological Laboratories Co ist eines der beliebtesten Unternehmen auf Eulerpool.com.

ROCE Details

Unraveling Immuno-Biological Laboratories Co's Return on Capital Employed (ROCE)

Immuno-Biological Laboratories Co's Return on Capital Employed (ROCE) is a financial metric that measures the company's profitability and efficiency with respect to the capital employed. It is calculated by dividing earnings before interest and tax (EBIT) by the employed capital. A higher ROCE indicates that the company is effectively utilizing its capital to generate profits.

Year-to-Year Comparison

Analyzing Immuno-Biological Laboratories Co's ROCE annually provides valuable insights into its efficiency in using its capital to generate profits. An increasing ROCE indicates improved profitability and operational efficiency, whereas a decrease might signal potential issues in capital utilization or business operations.

Impact on Investments

Immuno-Biological Laboratories Co's ROCE is a critical factor for investors and analysts for evaluating the company’s efficiency and profitability. A higher ROCE can make the company an attractive investment, as it often signifies that the firm is generating adequate profits from its employed capital.

Interpreting ROCE Fluctuations

Changes in Immuno-Biological Laboratories Co’s ROCE are attributed to variations in EBIT or the capital employed. These fluctuations offer insights into the company’s operational efficiency, financial performance, and strategic financial management, assisting investors in making informed investment decisions.

Frequently Asked Questions about Immuno-Biological Laboratories Co stock

What is the ROCE (Return on Capital Employed) of Immuno-Biological Laboratories Co this year?

The ROCE of Immuno-Biological Laboratories Co is 0.08 undefined this year.

How has the ROCE (Return on Capital Employed) of Immuno-Biological Laboratories Co developed compared to the previous year?

The ROCE of Immuno-Biological Laboratories Co has increased by -192.29% decreased compared to the previous year.

What does a high ROCE (Return on Capital Employed) mean for investors of Immuno-Biological Laboratories Co?

A high Return on Capital Employed (ROCE) indicates that Immuno-Biological Laboratories Co has efficient capital utilization and is able to achieve a higher return on its invested capital. This can be appealing to investors.

What does a low ROCE (Return on Capital Employed) mean for investors of Immuno-Biological Laboratories Co?

A low ROCE (Return on Capital Employed) can indicate that Immuno-Biological Laboratories Co has an inefficient utilization of its capital and may have difficulty in achieving a satisfactory return on its invested capital. This can be uncertain or unattractive for investors.

How does an increase in ROCE from Immuno-Biological Laboratories Co impact the company?

An increase in the ROCE of Immuno-Biological Laboratories Co can be an indicator of improved company efficiency and show that it is achieving higher profits in relation to its investments.

How does a reduction in the ROCE of Immuno-Biological Laboratories Co affect the company?

A decrease in ROCE of Immuno-Biological Laboratories Co can be an indicator of deteriorated efficiency of the company, indicating that it is generating lower profits in relation to its investments.

What are some factors that can influence the ROCE of Immuno-Biological Laboratories Co?

Some factors that can affect Immuno-Biological Laboratories Co's ROCE include efficiency in managing assets, profitability of investments, cost efficiency, and market conditions.

Why is the ROCE of Immuno-Biological Laboratories Co so important for investors?

The ROCE of Immuno-Biological Laboratories Co is important for investors as it is an indicator of the company's efficiency and shows how successful the company is in relation to its investments. A high ROCE can indicate strong financial performance of the company.

What strategic measures can Immuno-Biological Laboratories Co take to improve the ROCE?

To improve the ROCE, Immuno-Biological Laboratories Co can take measures such as increasing efficiency in asset management, optimizing investments, cost savings, and exploring new revenue sources. It is important for the company to conduct a thorough review of its operations to determine the best strategic actions to improve the ROCE.

How much dividend does Immuno-Biological Laboratories Co pay?

Over the past 12 months, Immuno-Biological Laboratories Co paid a dividend of 5 JPY . This corresponds to a dividend yield of about 1.13 %. For the coming 12 months, Immuno-Biological Laboratories Co is expected to pay a dividend of 0 JPY.

What is the dividend yield of Immuno-Biological Laboratories Co?

The current dividend yield of Immuno-Biological Laboratories Co is 1.13 %.

When does Immuno-Biological Laboratories Co pay dividends?

Immuno-Biological Laboratories Co pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Immuno-Biological Laboratories Co?

Immuno-Biological Laboratories Co paid dividends every year for the past 0 years.

What is the dividend of Immuno-Biological Laboratories Co?

For the upcoming 12 months, dividends amounting to 0 JPY are expected. This corresponds to a dividend yield of 0 %.

In which sector is Immuno-Biological Laboratories Co located?

Immuno-Biological Laboratories Co is assigned to the 'Health' sector.

Wann musste ich die Aktien von Immuno-Biological Laboratories Co kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Immuno-Biological Laboratories Co from 6/28/2013 amounting to 50 JPY, you needed to have the stock in your portfolio before the ex-date on 3/27/2013.

When did Immuno-Biological Laboratories Co pay the last dividend?

The last dividend was paid out on 6/28/2013.

What was the dividend of Immuno-Biological Laboratories Co in the year 2023?

In the year 2023, Immuno-Biological Laboratories Co distributed 0 JPY as dividends.

In which currency does Immuno-Biological Laboratories Co pay out the dividend?

The dividends of Immuno-Biological Laboratories Co are distributed in JPY.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Immuno-Biological Laboratories Co

Our stock analysis for Immuno-Biological Laboratories Co Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Immuno-Biological Laboratories Co Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.